Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1M Buy
58,300
+52,300
+872% +$17.9M 0.03% 460
2026
Q1
$2.11M Sell
6,000
-12,500
-68% -$4.46M ﹤0.01% 1810
2025
Q4
$6.06M Buy
18,500
+17,600
+1,956% +$5.58M 0.01% 1039
2025
Q3
$254K Buy
+900
New +$261K ﹤0.01% 3080
2025
Q2
Sell
-3,300
Closed -$1.03M 3202
2025
Q1
$1.03M Sell
3,300
-200
-6% -$59.1K ﹤0.01% 1788
2024
Q4
$912K Buy
3,500
+900
+35% +$267K ﹤0.01% 1788
2024
Q3
$838K Hold
2,600
﹤0.01% 1732
2024
Q2
$812K Buy
+2,600
New +$764K ﹤0.01% 1567

Other funds holding AMGN

Paul Tudor Jones's AMGN Position: Q4 2025 in Review

Paul Tudor Jones sold out of Amgen (AMGN) in Q4 2025, closing a stake of 119,834 shares — an estimated $38M sold.

Paul Tudor Jones first reported a position in AMGN in Q2 2013 and held it in 34 quarters. The position peaked at $46.7M in Q1 2024. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Paul Tudor Jones reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 119,834 Amgen shares in Q4 2025, an estimated $38M.
  • Paul Tudor Jones first reported a position in Amgen in Q2 2013 and held it in 34 quarters.
  • Paul Tudor Jones's Amgen position peaked at $46.7M in Q1 2024.
  • 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.